Press release
Global Pancreatic Cancer Drugs Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026
To Request a Sample of our Report on Global Pancreatic Cancer Drugs Market: https://www.omrglobal.com/request-sample/pancreatic-cancer-drugs-market
The drug may be an alternative for a small percentage of people suffering from unresectable pancreatic cancer. It works by blocking the ability of cancer cells’ to avoid an immune attack. Cancers with high microsatellite instability (MSI) have been demonstrated to be mainly prone to treatment with Keytruda. High MSI can be found in pancreatic cancers, however, it is not common. Targeted therapies that are available for the treatment of pancreatic cancers include Erlotinib and Larotrectinib (Vitrakvi). The US FDA approved Erlotinib for patients living with advanced pancreatic cancer along with the chemotherapy drug Gemzar (gemcitabine).
Erlotinib is used to block the epidermal growth factor receptor (EGFR) effect. EGFR is a protein that can become abnormal and support the growth and spread of cancer. One of the major instance for targeted therapy under trial is Lupin’s MEK inhibitor compound (LNP3794). In September 2019, Boehringer Ingelheim and Lupin Ltd. declared a licensing, development, and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as an effective targeted therapy for patients suffering from difficult-to-treat cancers. This collaboration intends for the development of Lupin’s lead MEK inhibitor compound along with one of innovative KRAS inhibitors of Boehringer Ingelheim for patients suffering from lung and gastrointestinal cancers harboring a comprehensive spectrum of oncogenic KRAS mutations.
KRAS mutations occur in one in seven of entire human metastatic cancers which makes it the most often mutated cancer-causing gene, with mutation rates of over 90% in pancreatic cancers, over 40% in colorectal cancers and over 30% in lung adenocarcinomas. Lupin’s MEK Inhibitor program has cleared early clinical stages. The emerging trials on such kinds of novel drugs will likely offer an opportunity for more reliable, accurate, and potential treatment for pancreatic cancer. This, in turn, is expected to accelerate the growth of the global pancreatic cancer drugs market.
(Get 15% Discount on Buying this Report)
A full Report of Global Pancreatic Cancer Drugs Market is Available at: https://www.omrglobal.com/industry-reports/pancreatic-cancer-drugs-market
Global Pancreatic Cancer Drugs Market- Segmentation
By Cancer Type
• Exocrine
• Endocrine
By Treatment Type
• Chemotherapy Drugs
• Targeted Therapy Drugs
• Immunotherapy Drugs
Global Pancreatic Cancer Drugs Market– Segment by Region
North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• The Middle East and Africa
Company Profiles
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Co.
• Cipla Ltd.
• Clovis Oncology, Inc.
• Eli Lilly and Co.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Kura Oncology, Inc.
• Lupin Ltd.
• Merck & Co., Inc.
• Novartis International AG
• Pfizer Inc.
• PharmaCyte Biotech, Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pancreatic-cancer-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pancreatic Cancer Drugs Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026 here
News-ID: 2320266 • Views: …
More Releases from Orion Market Research
Connector Market Size Unlocking New Opportunities for Success
The global Connector Market is estimated to be valued at USD 85.2 billion in 2024 and is projected to reach approximately USD 142.8 billion by 2033, growing at a CAGR of 5.8% during the forecast period from 2025 to 2033.
Connector Market Overview:
The Connector Market is experiencing strong growth, fueled by rapid advancements in telecommunications, consumer electronics, automotive, and industrial automation. Connectors are critical components for enabling electrical signal transmission and…
Natural Solubilizers Market Accelerating Growth with Future Market Size Strategi …
The global Natural Solubilizers Market is estimated to be valued at USD 725.4 million in 2024 and is projected to reach approximately USD 1,264.7 million by 2033, growing at a CAGR of 6.4% during the forecast period from 2025 to 2033.
Natural Solubilizers Market Overview:
The Natural Solubilizers Market is expanding steadily due to rising consumer preference for clean-label and eco-friendly ingredients across food, cosmetics, and pharmaceutical industries. Natural solubilizers help incorporate…
Mobile Phone Chips Market Accelerating Growth with Future Market Size Strategies …
The global Mobile Phone Chips Market is estimated to be valued at USD 138.5 billion in 2024 and is projected to reach approximately USD 247.6 billion by 2033, growing at a CAGR of 6.8% during the forecast period from 2025 to 2033.
Mobile Phone Chips Market Overview:
The Mobile Phone Chips Market is witnessing robust growth driven by increasing smartphone adoption, rising demand for high-performance devices, and the expansion of 5G networks…
Military Training Aircraft Market Size Opportunities and Challenges for the Futu …
The global Military Training Aircraft Market is estimated to be valued at USD 9.7 billion in 2024 and is projected to reach approximately USD 14.8 billion by 2033, growing at a CAGR of 4.8% during the forecast period from 2025 to 2033.
Military Training Aircraft Market Overview:
The Military Training Aircraft Market is growing steadily due to rising defense budgets and the increasing need for advanced pilot training programs worldwide. These aircraft…
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database.
In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests.
On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…
